Otc - Active Ingredient
STYPHNOLOBIUM JAPONICUM FLOWER BUD
EPIGALLOCATECHIN GALLATE
ASTRAGALUS GUMMIFER ROOT
FRITILLARIA THUNBERGII WHOLE
PLATYCODON GRANDIFLORUS WHOLE
Pulmonary Nodule Capsule
FDA Label NDC 85631-011
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Bispit Canada Ltd. for the product Pulmonary Nodule (NDC 85631-011). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, otc - keep out of reach of children, otc - purpose, indications & usage, inactive ingredient, warnings, dosage & administration, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Otc - Keep Out Of Reach Of Children
Store properly and out of reach of children.
Otc - Purpose
This product is formulated to help peopleprevent and improve symptoms of lungnodules.
Indications & Usage
Suitable for:◆Healthy adults who are concerned aboutrespiratory health;◆Long-term smokers, those exposed tosecond-hand smoke, and people who arelong exposed to dust, harmful gases, andcooking fumes;People with lung problems such as coughsthose with sensitive respiratory systemsthose susceptible to viral infections, andthose with poor immunity
Inactive Ingredient
CALCIUM CARBONATE
CARBOXYMETHYLCELLULOSE SODIUM
Warnings
This product is not a substitute formedication.For severe lung diseases such aslung cancer, pulmonary fibrosis, and severepneumonia, please follow your doctor'sadvice:Not recommended for pregnant women,breastfeeding women, infants, and children;Not recommended for those allergic to theproduct's ingredients;
Dosage & Administration
Dosage: For prevention: once per day,2tablets per dosing.Patient with nodule: twice per day, 2 tabletsper dosing (doubled for severe patient).
Package Label.Principal Display Panel
Labeling (85631 011 01)
* Please review the disclaimer below.
